Total Payments
$9,236
2022 Payments
$45.24
Companies
35
Transactions
249
Medicare Patients
757
Medicare Billing
$64,624
Payment Breakdown by Category
Research$5,403 (58.5%)
Food & Beverage$3,833 (41.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $5,403 | 3 | 58.5% |
| Food and Beverage | $3,833 | 246 | 41.5% |
Payments by Type
Research
$5,403
3 transactions
General
$3,833
246 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $5,403 | 3 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $479.57 | 32 | $0 (2021) |
| Allergan, Inc. | $406.91 | 29 | $0 (2020) |
| Astellas Pharma US Inc | $272.28 | 17 | $0 (2021) |
| SANOFI PASTEUR INC. | $237.07 | 4 | $0 (2020) |
| Amgen Inc. | $236.78 | 13 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $233.42 | 19 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $211.04 | 15 | $0 (2021) |
| Novo Nordisk Inc | $170.56 | 13 | $0 (2020) |
| PFIZER INC. | $162.63 | 11 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $45.24 | 2 | Eli Lilly and Company ($31.00) |
| 2021 | $227.89 | 14 | AstraZeneca Pharmaceuticals LP ($51.48) |
| 2020 | $5,924 | 38 | Eli Lilly and Company ($5,372) |
| 2019 | $873.31 | 58 | Allergan Inc. ($144.55) |
| 2018 | $1,045 | 74 | Allergan Inc. ($168.87) |
| 2017 | $1,120 | 63 | SANOFI-AVENTIS U.S. LLC ($217.68) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/16/2022 | Eli Lilly and Company | — | — | In-kind items and services | $31.00 | Research |
| Study: THE EFFECT OF TIRZEPATIDE VERSUS DULAGLUTIDE ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES (SURPASS CVOT) | ||||||
| 01/27/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: UROLOGY | ||||||
| 05/03/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Cardiovascular | ||||||
| 04/12/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $11.40 | General |
| Category: Cardiovascular | ||||||
| 04/05/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: UROLOGY | ||||||
| 03/29/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: VACCINES | ||||||
| 03/15/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/25/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/24/2021 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 01/28/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: UROLOGY | ||||||
| 01/25/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/21/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/28/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Respiratory | ||||||
| 12/17/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Cardiovascular | ||||||
| 12/10/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $12.94 | General |
| Category: Neurology | ||||||
| 12/09/2020 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/07/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Neuroscience | ||||||
| 10/08/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: UROLOGY | ||||||
| 09/18/2020 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: CNS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| THE EFFECT OF TIRZEPATIDE VERSUS DULAGLUTIDE ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES (SURPASS CVOT) | Eli Lilly and Company | $5,403 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 220 | 313 | $34,080 | $14,589 |
| 2020 | 12 | 537 | 949 | $93,486 | $50,035 |
Total Patients
757
Total Services
1,262
Medicare Billing
$64,624
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 88 | 118 | $13,216 | $4,384 | 33.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 34 | 34 | $5,610 | $4,342 | 77.4% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 31 | 74 | $6,660 | $2,590 | 38.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 32 | $5,184 | $1,998 | 38.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 36 | 55 | $3,410 | $1,276 | 37.4% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 42 | 193 | $17,370 | $12,236 | 70.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 134 | 266 | $29,792 | $12,132 | 40.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 95 | 95 | $15,675 | $10,785 | 68.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 81 | 84 | $13,608 | $4,740 | 34.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 56 | 105 | $6,510 | $2,856 | 43.9% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 22 | 22 | $2,574 | $2,562 | 99.5% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 15 | 51 | $3,672 | $2,553 | 69.5% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 15 | 15 | $1,125 | $914.70 | 81.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 27 | 29 | $1,102 | $469.39 | 42.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 22 | 22 | $770.00 | $356.10 | 46.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 11 | 39 | $1,092 | $335.12 | 30.7% |
| 81002 | Urinalysis, manual test | Office | 2020 | 17 | 28 | $196.00 | $96.95 | 49.5% |
About Dr. Michael Killpack, MD
Dr. Michael Killpack, MD is a Hospitalist healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1588714091.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Killpack, MD has received a total of $9,236 in payments from pharmaceutical and medical device companies, with $45.24 received in 2022. These payments were reported across 249 transactions from 35 companies. The most common payment nature is "" ($5,403).
As a Medicare-enrolled provider, Killpack has provided services to 757 Medicare beneficiaries, totaling 1,262 services with total Medicare billing of $64,624. Data is available for 2 years (2020–2021), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Salt Lake City, UT
- Active Since 01/10/2007
- Last Updated 01/15/2021
- Taxonomy Code 208M00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588714091
Products in Payments
- VRAYLAR (Drug) $309.66
- TOUJEO (Drug) $303.16
- PENTACEL (Drug) $205.80
- MYRBETRIQ (Drug) $198.12
- Aimovig (Biological) $160.64
- ELIQUIS (Drug) $137.09
- Vascepa (Drug) $130.92
- TRULICITY (Drug) $94.53
- FARXIGA (Drug) $89.11
- JANUVIA (Drug) $88.38
- ARISTADA (Drug) $87.29
- SOLIQUA (Drug) $86.05
- XARELTO (Drug) $83.75
- TRADJENTA (Drug) $79.82
- BYSTOLIC (Drug) $76.32
- JARDIANCE (Drug) $74.69
- Myrbetriq (Drug) $74.16
- XIFAXAN (Drug) $59.97
- MYDAYIS (Drug) $57.43
- Victoza (Drug) $53.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Salt Lake City
Donald No, M.d, M.D
Hospitalist — Payments: $636.00
Hospitalist $636.00
Matthew Siegel, Md, MD
Hospitalist — Payments: $423.99
Hospitalist $423.99
Rebecca Kim, M.d, M.D
Hospitalist — Payments: $306.71
Hospitalist $306.71
Dr. Margaret Baron, M.d, M.D
Hospitalist — Payments: $261.80
Hospitalist $261.80
Dr. Melissa Bentley, M.d, M.D
Hospitalist — Payments: $261.63
Hospitalist $261.63
Myung Lee, M.d, M.D
Hospitalist — Payments: $213.08
Hospitalist $213.08